日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prediction of Monoclonal Antibodies Pharmacokinetics in Human: Identification of a Reference Neonatal Fc Receptor (FcRn) Binding Affinity Using Physiologically Based Pharmacokinetic (PBPK) Modeling

预测人体单克隆抗体药代动力学:利用生理药代动力学(PBPK)模型鉴定参考新生儿Fc受体(FcRn)结合亲和力

Benamara, Salih; Sjögren, Erik; Gattacceca, Florence; Chenel, Marylore; Deslandes, Antoine; Nguyen, Laurent; Teutonico, Donato

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025

2025年开放系统药理学社区会议(OSP-CC)论文集

Cordes, Henrik; Annaert, Pieter; Balazki, Pavel; Benamara, Salih; Bonan, Rodolfo Hernandes; Butler, Andrew; Chenel, Marylore; Cui, Yunhai; Dallmann, André; de Witte, Wilhelmus E A; Demeester, Cleo; Feick, Denise; Gattacceca, Florence; Geci, René; Gerebtzoff, Grégori; Gruber, Andrea; Guimarães, Mariana; Hamadeh, Abdullah; Hanke, Nina; Ibarra, Manuel; Ince, Ibrahim; Kanacher, Tobias; Kuepfer, Lars; Mil, Felix; Montaseri, Ghazal; Nauwelaerts, Nina; Proenca, Susana; Schaller, Stephan; Schlender, Jan Frederik; Schneider, Annika R P; Sjögren, Erik; Solodenko, Juri; Staab, Alexander; Vrenken, Paul; Troisi, Carla; Teutonico, Donato

Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference

利用开源解决方案:来自首届开放系统药理学 (OSP) 社区大会的见解

Dallmann, André; Feick, Denise; Balazki, Pavel; Benamara, Salih; Burghaus, Rolf; Chenel, Marylore; Choi, Siak-Leng; Cordes, Henrik; Guimarães, Mariana; Hamadeh, Abdullah; Ince, Ibrahim; Job, Kathleen M; Kanacher, Tobias; Kovar, Andreas; Kuepfer, Lars; Lippert, Jörg; Macente, Julia; Nauwelaerts, Nina; Niederalt, Christoph; Peters, Sheila; Proença, Susana; Sato, Masanobu; Schaller, Stephan; Schlender, Jan Frederik; Schneider, Annika; Sjögren, Erik; Solodenko, Juri; Staab, Alexander; Vrenken, Paul; Wendl, Thomas; de Witte, Wilhelmus E A; Teutonico, Donato

The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder Perspective

体外-体内相关性在模型指导药物开发中的作用演变:多方利益相关者的视角

Chenel, Marylore; Fouliard, Sylvain; Hansson, Emma; Brendel, Karl; Jacobs, Matthieu; Lennernäs, Hans; Sjögren, Erik; Bergstrand, Martin

Model-Informed Drug Development of a Sustained Release Formulation of Flucytosine in the Treatment of Cryptococcal Meningitis: A Case Study Using Physiologically Based Pharmacokinetic Modeling

基于模型指导的氟胞嘧啶缓释制剂治疗隐球菌性脑膜炎的药物开发:以生理药代动力学模型为例的案例研究

Eriksson, Johanna; Sjögren, Erik; Gillon, Jean-Yves; Caplain, Henri; Goyal, Vishal; Satam, Vijay; Robinson, Stephen; Ribeiro, Isabela; Chenel, Marylore

Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers

三种新型口服缓释颗粒剂与含500毫克氟胞嘧啶的速释片剂相比的生物利用度:一项在健康志愿者中进行的随机、开放标签、交叉研究

Goyal, Vishal; Krantz, Edrich; Simon, Francois; Neven, Anouk; Eriksson, Johanna; Saayman, Amaria; Ibnou Zekri Lassout, Nabila; Louis, Mathieu; Robinson, Stephen; Deshmukh, Abhijit; Antarkar, Amit; Ruffell, Carol; Victor, Sarika; Chenel, Marylore; Celebic, Aljosa; Caplain, Henri; Gillon, Jean-Yves; Ribeiro, Isabela

Bioavailability of a novel sustained-release pellet formulation of 5-flucytosine in healthy-fed participants for use in patients with cryptococcal meningitis

在健康受试者中,一种新型缓释型5-氟胞嘧啶颗粒制剂的生物利用度,用于治疗隐球菌性脑膜炎患者。

Ibnou Zekri Lassout, Nabila; Goyal, Vishal; Krantz, Edrich; Simon, Francois; Neven, Anouk; Eriksson, Johanna; Saayman, Amaria; Satam, Vijay; Ruffell, Carol; Victor, Sarika; Chenel, Marylore; Celebic, Aljosa; Caplain, Henri; Gillon, Jean-Yves; Deshmukh, Abhijit; Antarkar, Amit; Sjögren, Eric; Ribeiro, Isabela

Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia

成人B细胞急性淋巴细胞白血病中宿主免疫系统、IL-7和UCART19同种异体CAR-T细胞相互作用的机制模型

Derippe, Thibaud; Fouliard, Sylvain; Marchiq, Ibtissam; Dupouy, Sandra; Almena-Carrasco, Maria; Geronimi, Julia; Declèves, Xavier; Chenel, Marylore; Mager, Donald E

Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm

免疫肿瘤学的定量系统药理学方法:将虚拟病人纳入研发范式

Chelliah, Vijayalakshmi; Lazarou, Georgia; Bhatnagar, Sumit; Gibbs, John P; Nijsen, Marjoleen; Ray, Avijit; Stoll, Brian; Thompson, R Adam; Gulati, Abhishek; Soukharev, Serguei; Yamada, Akihiro; Weddell, Jared; Sayama, Hiroyuki; Oishi, Masayo; Wittemer-Rump, Sabine; Patel, Chirag; Niederalt, Christoph; Burghaus, Rolf; Scheerans, Christian; Lippert, Jörg; Kabilan, Senthil; Kareva, Irina; Belousova, Natalya; Rolfe, Alex; Zutshi, Anup; Chenel, Marylore; Venezia, Filippo; Fouliard, Sylvain; Oberwittler, Heike; Scholer-Dahirel, Alix; Lelievre, Helene; Bottino, Dean; Collins, Sabrina C; Nguyen, Hoa Q; Wang, Haiqing; Yoneyama, Tomoki; Zhu, Andy Z X; van der Graaf, Piet H; Kierzek, Andrzej M

Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach

在EGFR抑制剂耐药的非小细胞肺癌异种移植模型中,通过联合使用MET抑制剂模拟吉非替尼疗效的恢复:一种基于肿瘤宿主模型的DEB方法

Tosca, Elena M; Gauderat, Glenn; Fouliard, Sylvain; Burbridge, Mike; Chenel, Marylore; Magni, Paolo